SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
With reference to the above subject, we have noticed few text errors in the news release filed today i.e. 11/08/2020 with the stock exchanges in relation to unaudited results, which we have now rectified and the corrected copy of news release is enclosed herewith. We request you to take this news release on your records. SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. August 11, 2020, approved the following along with other business matters. 1) Took on record and approved the Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter ended 30th June, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Review Reports of the Statutory Auditors. SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. August 11, 2020, approved the following along with other business matters. 1) Took on record and approved the Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter ended 30th June, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Review Reports of the Statutory Auditors. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated 04th August, 2020 regarding the Date and Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. 05th August, 2020 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/NoticeofBoardMeeting.aspx This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Tuesday, The 11Th August, 2020.
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2020 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 11th August, 2020 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended 30th June, 2020 and related matters. To consider and approve Suven Life Employees Stock Option Scheme 2020 under SEBI (Share Based Employee Benefits) Regulations, 2014 subject to necessary approvals. You are requested to take this notice on your record. SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 121211 Name of the Signatory :- Shrenik SoniDesignation :- Company Secretary and Compliance Officer SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended June 30, 2020
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg.24(A)-Annual Secretarial Compliance
With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report of the Company from M/s. D. Renuka, Practicing Company Secretary, Hyderabad for the year ended 31st March, 2020, in terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019. We request you to take this document on your record. SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended June 30, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by M/s. KFin Technologies Private Limited, Registrar & Transfer Agent of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Private Limited dated July 04, 2020 are enclosed for your reference. This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis and balances for the year ended March 31st, 2020. We request you to take this document on your record.